<DOC>
	<DOCNO>NCT02576457</DOCNO>
	<brief_summary>The purpose study determine whether BMS-936559 safe desire pharmacologic activity patient severe sepsis .</brief_summary>
	<brief_title>Safety , Pharmacokinetics Pharmacodynamics BMS-936559 Severe Sepsis</brief_title>
	<detailed_description />
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com Severe sepsis septic shock least 24 hour Documented suspected infection Sepsisinduced immunosuppression Men woman â‰¥ 18 year old Autoimmune disease Organ transplant bone marrow transplant Cancer treat past 6 month Hepatitis B virus ( HBV ) Infection Human Immunodeficiency Virus ( HIV ) infection therapy prior episode sepsis Hepatitis C virus ( HCV ) infection still virus ( cure )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>